Dendreon (DNDN) Now a Double on the Year Amid M&A Speculation
Tweet
Share
E-mail
Get Alerts DNDN Hot Sheet
Join SI Premium – FREE
Dendreon (Nasdaq: DNDN) continues its impressive year-to-date rally with takeover speculation apparently the main driver.
Shares are up over 9 percent today to $15.46 and up 103 percent on the year.
Amgen (Nasdaq: AMGN) has been mentioned as a possible suitor and recently hired CEO John Johnson brings a "M&A History."
Shares are up over 9 percent today to $15.46 and up 103 percent on the year.
Amgen (Nasdaq: AMGN) has been mentioned as a possible suitor and recently hired CEO John Johnson brings a "M&A History."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Amgen (AMGN) PT Raised to $362 at Morgan Stanley
- Amgen (AMGN) PT Raised to $457 at Piper Sandler
Create E-mail Alert Related Categories
Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
